Blue Horseshoe Stocks: FWDG, SCYX Updates & More

FutureWorld Corp. FWDG

On Monday, we put FWDG on our radar as a result of a PR we caught that morning outlining an upcoming share dividend. Those who own shares of FWDG as of next Thursday, April 30th will receive dividend shares of HempTech Corp (>>View Website)

We mentioned that we’d be tracking this play leading up to the dividend date, and it appears to have found a base of support at .0024 late this week. From that level, yesterday the stock rebounded back to .0034 (+42%). The next area of resistance on the FWDG chart is the 50DMA of .0038.


SCYNEXIS, Inc. SCYX

SCYX appeared in yesterday’s extended watchlist, and put up a noteworthy intraday performance.The stock saw a brief low of 8.15 first thing in the morning, and ran into the close at 9.99. That worked out to a 22.5% increase on the day, and it come on substantial volume to the tune of just over 51X the monthly average trading volume.

Anytime we see a stock close with that kind of momentum, it’s one that we’ll monitor closely in following sessions. We will of course be on the lookout for both continued momentum as well as an eventual consolidation that could lead us to opportunities on the bounce.


Pazoo, Inc. PZOO

In addition to bringing us multiple chances at sizable intraday gains over the past three weeks, PZOO is also building itself a beauty of a chart. We’ve seen continual progress since observing a low of .0049 (04/06) as the stock managed a subsequent high of .0125 (+155%), and has registered a higher low every single day this week. It’s easily observable on the chart snapshot we’ve included below.


The company also remains active in the news; last week promising full repayment of one of its convertible notes within ten days, and this morning informing us that they met their obligations totaling $400K.  Pazoo also highlighted its plans to repay another note to a different firm in coming weeks. It shows a real commitment to cleaning up its books and moving in a positive direction, so we’ll want to stay attuned to the news wires for future updates.

This Morning’s PR:

WHIPPANY, N.J., April 24, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC Pinks:PZOO) (German WKN#: A1J3DK), is pleased to announce that as of today, the company has completely repaid the total of its obligations on its Convertible Promissory Notes to Union Capital LLC. Pazoo announced on April 15th its intention to pay off Union Capital within ten days’ time. Pazoo made good today on its intentions. Pazoo’s next steps will be to pay off the Eastmore Capital Note within the next few weeks.

Pazoo felt it’s extremely important to let shareholders and the public know that it continues to meet its commitments, and assure the public that Pazoo is taking affirmative steps to prevent any conversions of these Notes into free trading shares of the company’s common stock. >> FULL PR


Added Notes:

Apple Inc. AAPL has been a beast all week in anticipation of earnings at the beginning of next week. The stock is gapping up this morning to highs that it hasn’t seen since February. We’ll be looking for a possible daytrading opportunity in the $130 Weekly Calls as the dip-and-rip is one of our favorite setups.

Amazon.com, Inc. AMZN will also be on our radars for a potential dip-and-rip scenario following its earnings beat. We’re going to monitor Calls in the $420-435 range.


Extended Watchlist:
MSTX, CLF, MCP, LOOK

Blue Horseshoe Stocks: PBR, INO, RAD Reviews & More

Petroleo Brasiliero, S.A. (Petrobras) PBR – Options

PBR has continued to perform this week after we caught it coming off its 52-week lows two Thursday’s ago. At that time one of our main areas of interest was the 05/01 $6.50 Calls, which we subsequently observed trading at a low of .22. This week they’ve attained a high of .71, marking off a tidy 222% move.

The last time we touched upon PBR options on Monday morning, it was in the process of pushing even higher, so we suggested the possibility of rolling up our strike price to  both the Weekly and May 1st $7 Calls, and that idea turned out to be a good one as well.

We’ve witnessed a trading range on the Weekly $7’s from .06 -.25, a whopping 316%, while the May 1st $7’s enjoyed an 87% run from .30 to .56.


Inovio Pharmaceuticals, Inc. INO 

INO stands among those stocks that we have covered the most over the years. An INO tag search of our archives yields no less than 30 results. We re-flagged it in yesterday’s premarket report and the timing was quite fortuitous.

Yesterday morning the company had announced it had been selected as the leader of a $45M DARPA program to develop practical treatments for the Ebola virus. It fueled a continued rise off of recent lows, and this morning’s news could contribute to that as well.  >> READ PR

INO heralded positive results from one of its studies, a DNA-based immunotherapy for the treatment of head and neck cancer. According to the CFO, the “initial data set from Inovio’s first cancer study provides encouraging evidence that we are on an important path to better optimized immunotherapy products.” >> READ PR

We’ll continue to keep watch over INO in the wake of these major developments.


Molycorp, Inc. MCP

MCP started showing up on our scanner back on March 23rd and 24th, when it was trading around .38. It retraced back to its 52-week low of .32 on the 27th.

After reappearing on our extended watchlist yesterday, it has traded as high as .62 in the premarket today; from a low of .484 that’s a 28% move up.

At .62, MCP had shown us a 94% overall move from its ultimate low set just the week before last. With gold and other precious metal prices on the rise again, we’ll continue to track MCP for more potential gain opportunities.


Rite-Aid Corp. RAD

We also wanted to make a quick mention of RAD. We tagged the stock for tracking back on December 4th and on that day we observed the lowest price the stock has traded at since then (5.48).

Since that time the stock has crept (and sometimes leaped) its way up the chart; it broke its 50DMA in early March, and managed break the $9-mark last Thursday, and then again yesterday. At Thursday’s high of 9.07, we had witnessed a total gain of 65%

Wall Street analysts are giving RAD high marks, and the stock is also receiving a 96% Overall “Buy” Rating at BARCHART.COM so we’ll certainly want to keep a close watch on RAD moving forward in the event that it sustains the bullish patterns it has been exhibiting over the past several months.


Extended Watchlist:
EXEL, OPXA, WPCS, MPET, MSTX, SLTD

Blue Horseshoe Stocks: BCLI Recap & More

BrainStorm Cell Therapeutics, Inc. BCLI

2015 is upon us and our first order of business is to address one of the stocks we tagged in Wednesday’s premarket report. BCLI had a strong session, as it pushed its way up from an early low of 4.02 to an aftyernoon high of 4.94; a solid +23% performance.

The strong session was apparently aided by the pre-emptive PR the company released which served as a reminder that results from Phase 2a trials of its ALS (Lou Gehrig’s Disease) treatment would be released on Monday. This morning the stock is gapping up wildly as anticipation grows, having already hit a premarket high of 7.28, which represents a total increase of 81% over the low we observed on New Year’s Eve.

Monday’s data release, which is expected to be positive, should most likely produce one of two effects. Either the results will beat expectations and facilitate another strong move, or they will fail to meet the mark and cause a pullback. In case of the latter, there may be rebound opportunities waiting just around the corner.



RedHill BioPharma Ltd. RDHL & NephroGenex, Inc. NRX

We also had this pair of standouts appear in Wednesday’s report, with each stock making a similar move. Both started the day with significant spikes in PPS, followed by a tapering off into the close.

RDHL made a sensational jump beginning almost immediately at the open running from 12.52 on up to 17.85 before its pullback, an intraday spike equaling 42.5%. Coincidentally, the stock ended the session having traded 42.5X its 3-month average volume.

NRX
saw an initial low of 12.96, followed by a healthy 39% run to a high of 17.98. This play would offer one more opportunity in the form of an intraday swing as it came down and rebounded off of the 12.60-mark before returning to 15.15, an added 20% move, bringing the day’s cumulative total of possible gains to 59% .


Extended Watchlist:
CUR, ARWR, CLF, MSTX, RAD